期刊文献+

p53通路相关基因和EZH2在鼻咽癌中的表达关系及意义 被引量:11

Expressions of p53 pathway genes and EZH2 in undifferentiated nasopharyngeal carcinoma
下载PDF
导出
摘要 目的探讨p53通路相关基因p53、mdm2、p63蛋白和EZH2在鼻咽癌中的表达关系和意义。方法用免疫组化法检测47例鼻咽未分化癌及12例慢性鼻咽炎中p53、mdm2、p63和EZH2蛋白的表达状况并分析其与临床参数、预后,以及相互关系。结果 p53、mdm2、p63及EZH2蛋白在鼻咽癌的阳性表达率分别为31.9%,85.1%,95.7%;mdm2、EZH2与p53蛋白的表达无关,EZH2与p63蛋白的表达呈正相关,p53与p63蛋白的表达呈正相关;EZH2和p63蛋白的高表达与T分期和临床分期的升高有关(P<0.05);EZH2蛋白的高表达组的五年无疾病生存率明显低于低表达组(P<0.05)。结论在鼻咽癌中mdm2的表达可能与p53蛋白失活的关系不大,p63蛋白的过表达可能与p53蛋白的失活有关,EZH2的过表达与鼻咽癌的进展及不良预后有关。 Objective To investigate the relationship between the expressions of p53 pathway genes and EZH2 in nasopharyngeal carcinoma (NPC). Methods The expression levels of p53, mdm2, p63 and EZH2 proteins were detected by immunohistochemistry in 47 cases of undifferentiated NPC and 12 cases of chronic nasopharyngitis, and their correlation to the clinical parameters and prognosis were analyzed. Results The protein expressions of p53, mdm2, p63 and EZH2 in NPC were 31.9%, 85.1%, and 95.7%, respectively. mdm2 and EZH2 was not correlated to p53 protein expression (P〉0.05); positive correlations was found between EZH2 and p63 expressions and between p53 and p63. The high expression of EZH2 and p63 proteins was correlated to advanced T stage and clinical stage of NPC (P〈0.05). The five-year disease-free survival rate in patients with high EZH2 protein expression was significantly lower than that in patients with low EZH2 expression. Conclusions mdm2 does not show an obvious correlation to p53 protein inactivation in NPC. p63 protein overexpression may be associated with p53 protein inactivation. The overexpression of EZH2 is correlated to NPC progression and poor prognosis
出处 《南方医科大学学报》 CAS CSCD 北大核心 2011年第6期1029-1033,共5页 Journal of Southern Medical University
基金 广东省医学科研基金(A2008802)
关键词 鼻咽癌 免疫组化 P53 MDM2 P63 EZH2 预后 nasopharyngeal carcinomas immunohistochemical EZH2 p53 mdm2 p63 prognosis
  • 相关文献

参考文献13

  • 1Giaccia AJ, Kastan MB. The complexity of p53 modulation: emerging patterns from divergent signals[J]. Genes Dev, 1998, 12 (19): 2973-83.
  • 2Murono, Yoshizaki, C-S Park. Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma[J]. Histopathology, 1999, 34(5): 432-8.
  • 3Bouska A, Eischen CM. Murine double minute 2: p53-independent roads lead to genome instability or death[J]. Trends Biochem Sci, 2009, 34(6): 279-86.
  • 4Crook T, Nicholls JM, Brooks L, et al. High level expression of data-Np63:a mechanism for the inactivation of p53in undifferentiated nasopharyngeal carcinoma(NPC)[J]? Oncogene, 2000,1900): 3439-44.
  • 5Westfall MD, Mays D J, Sniezek JC, et al. The Delta-Np63 Alpha Phosphoprotein Binds the p21 and 14-3-3 Sigma Promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations [J]. Mol Cell Biol, 2003, 23 (7): 2264-76.
  • 6郭灿,刘正春,陈真诚,唐艳.p63与p21在鼻咽癌细胞中的表达及相互作用的初步研究[J].激光生物学报,2009,18(3):379-382. 被引量:3
  • 7Ding L, Erdmann C, Chinnaiyan AM, et al. Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissue[J]. Cancer Res, 2006, 66(8): 4095-9.
  • 8Varambally S, Dhanasekaran SM, Zhou M, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer [J]. Nature, 2002, 419(6907): 572-3.
  • 9Raaphorst FM, Meijer C J, Fieret E, et al. Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene [J]. Neoplasia, 2003, 5(6): 481-8.
  • 10Bracken AP, Pasini D, Capra M, et al. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer[J]. EMBO, 2003, 22(20): 5323-35.

二级参考文献1

共引文献2

同被引文献77

引证文献11

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部